LINDSAY GWALTNEY: Open Payments
NPI 1194369884 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,025 in 57 payments from 11 companies in 2025. Trend: 2023 $47 · 2024 $1,045 · 2025 $9,025
Speaker / faculty: $4,400Consulting: $2,994Food & beverage: $1,588Education: $43
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 15 | $4,538 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $1,994 |
| GENZYME CORPORATION | 2 | $1,190 |
| Sequel Med Tech, LLC | 25 | $777 |
| Novo Nordisk Inc | 6 | $183 |
| SANOFI-AVENTIS U.S. LLC | 1 | $108 |
| Lilly USA, LLC | 1 | $98 |
| Dexcom, Inc. | 3 | $50 |
| Mannkind Corporation | 1 | $43 |
| Medtronic, Inc. | 1 | $26 |
Products named: OMNIPOD, TWIIST, Wegovy, TZIELD, Dexcom G6 Transmitter, AFREZZA, MINIMED 780G, Ozempic.
Industry payments across MO — which companies pay providers there.
